tiprankstipranks
Trending News
More News >
CKD Corporation (JP:6407)
:6407
Japanese Market

CKD Corporation (6407) AI Stock Analysis

Compare
1 Followers

Top Page

JP

CKD Corporation

(6407)

Rating:78Outperform
Price Target:
¥2,631.00
▲(10.31%Upside)
CKD Corporation's overall stock score is driven by strong financial performance and an attractive valuation. The financial stability and growth potential are significant strengths, complemented by a relatively low P/E ratio and high dividend yield. Technical indicators suggest caution due to potential overbought conditions, but the overall outlook remains positive.

CKD Corporation (6407) vs. iShares MSCI Japan ETF (EWJ)

CKD Corporation Business Overview & Revenue Model

Company DescriptionCKD Corporation (6407) is a Japanese company specializing in the design, manufacture, and sale of automation technology and components. The company operates primarily in sectors such as industrial automation, pneumatic control systems, and fluid control systems. CKD's core products include automatic machinery, pneumatic equipment, and fluid control components, which are utilized in various industries, including automotive, electronics, and healthcare.
How the Company Makes MoneyCKD Corporation generates revenue through the sale of its automation technology and component products. The company's key revenue streams include the sales of pneumatic control systems, which are used in manufacturing processes to automate and improve efficiency; fluid control systems, which manage and regulate the flow of liquids and gases in industrial applications; and automatic machinery that enhances production capabilities across various industries. CKD also benefits from strategic partnerships and collaborations with industrial manufacturers, allowing it to expand its market reach and drive sales growth. Additionally, the company invests in research and development to innovate and improve its product offerings, maintaining its competitive edge and appeal to a broad customer base.

CKD Corporation Financial Statement Overview

Summary
CKD Corporation exhibits strong financial performance with robust growth and profitability. The income statement shows a strong gross profit margin and notable revenue growth. The balance sheet reflects a solid capital structure with low leverage, and the cash flow statement highlights improved cash generation capabilities.
Income Statement
87
Very Positive
CKD Corporation's income statement demonstrates robust performance with a strong gross profit margin of 28.4% and a net profit margin of 8.7% for 2025. Revenue growth is notable at 15.8%, indicating a healthy upward trajectory. The EBIT and EBITDA margins, at 12.2% and 17.2% respectively, underline effective cost management and operational efficiency. The consistent revenue growth and profitability margins suggest a solid market position and effective business strategy.
Balance Sheet
82
Very Positive
The balance sheet of CKD Corporation shows a solid equity ratio of 64.7%, reflecting a strong capital structure with significant equity backing. The debt-to-equity ratio is relatively low at 0.26, indicating prudent leverage levels. ROE stands at 9.9%, showing efficient utilization of shareholder funds. Overall, the company's balance sheet is stable, with low financial risk and good asset management.
Cash Flow
78
Positive
CKD Corporation's cash flow statement reveals a remarkable turnaround with a positive free cash flow of ¥13.47 billion in 2025, compared to negative values in previous years, indicating improved cash generation. The operating cash flow to net income ratio is 1.42, suggesting strong cash conversion efficiency. The free cash flow to net income ratio of 0.99 reflects substantial cash available after capital expenditures. These metrics highlight improved cash management and operational cash generation capabilities.
Breakdown
TTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income StatementTotal Revenue
149.25B155.63B134.43B159.46B142.20B106.72B
Gross Profit
43.10B44.16B38.04B46.40B40.89B28.77B
EBIT
17.28B19.02B13.11B21.17B17.88B7.70B
EBITDA
24.24B26.73B20.31B28.37B23.79B13.21B
Net Income Common Stockholders
11.44B13.52B8.34B14.79B12.57B5.27B
Balance SheetCash, Cash Equivalents and Short-Term Investments
29.40B35.33B28.30B28.57B34.53B36.38B
Total Assets
214.31B210.87B208.28B185.63B172.51B152.73B
Total Debt
35.38B35.80B37.53B18.63B17.89B20.41B
Net Debt
5.98B468.00M9.79B-9.94B-16.63B-15.96B
Total Liabilities
79.80B74.34B79.19B65.90B62.94B55.11B
Stockholders Equity
134.51B136.52B129.10B119.73B109.57B97.50B
Cash FlowFree Cash Flow
0.0013.47B-12.99B-702.00M4.12B14.56B
Operating Cash Flow
0.0019.17B7.60B11.05B12.35B17.52B
Investing Cash Flow
0.00-6.06B-20.23B-12.79B-8.54B-2.79B
Financing Cash Flow
0.00-6.18B13.05B-5.74B-6.26B2.42B

CKD Corporation Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2385.00
Price Trends
50DMA
2121.34
Positive
100DMA
2203.70
Positive
200DMA
2414.24
Negative
Market Momentum
MACD
56.41
Positive
RSI
59.24
Neutral
STOCH
73.09
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6407, the sentiment is Positive. The current price of 2385 is above the 20-day moving average (MA) of 2305.20, above the 50-day MA of 2121.34, and below the 200-day MA of 2414.24, indicating a neutral trend. The MACD of 56.41 indicates Positive momentum. The RSI at 59.24 is Neutral, neither overbought nor oversold. The STOCH value of 73.09 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6407.

CKD Corporation Peers Comparison

Overall Rating
UnderperformOutperform
Sector (66)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
¥159.83B11.52
3.52%15.78%62.07%
77
Outperform
$230.51B19.984.82%3.35%-6.42%-15.92%
76
Outperform
€222.99B12.0614.03%2.56%4.59%64.99%
76
Outperform
¥145.61B12.49
2.58%20.05%-26.75%
75
Outperform
¥191.22B8.578.48%5.16%4.64%24.27%
74
Outperform
¥239.32B19.80
1.12%16.07%61.09%
66
Neutral
$4.51B12.225.40%3.63%4.14%-12.01%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:6407
CKD Corporation
2,332.00
-799.27
-25.53%
JP:6507
Sinfonia Technology Co., Ltd.
8,770.00
5,415.31
161.43%
JP:6622
Daihen Corporation
6,160.00
-1,794.30
-22.56%
JP:6371
Tsubakimoto Chain Co.
1,800.00
-142.00
-7.31%
JP:6508
Meidensha Corporation
4,780.00
806.72
20.30%
JP:6134
Fuji
2,435.00
61.10
2.57%

CKD Corporation Corporate Events

CKD Corporation Revises Financial Results for FY 2025
Jun 13, 2025

CKD Corporation announced corrections to its Consolidated Financial Results for the fiscal year ended March 31, 2025. The revisions, which include updated numerical data, are intended to provide more accurate financial information. These corrections could impact stakeholders’ understanding of the company’s financial health and operational efficiency.

The most recent analyst rating on (JP:6407) stock is a Buy with a Yen3400.00 price target. To see the full list of analyst forecasts on CKD Corporation stock, see the JP:6407 Stock Forecast page.

CKD Corporation Announces Executive Personnel Changes
May 13, 2025

CKD Corporation announced executive personnel changes, effective May 13, 2025. Akihiro Ueno has been appointed as Executive Officer while retaining his role as President of CKD Korea Corporation. Akihiro Ito has been promoted to Fellow and General Manager of the New Business Development Office. Additionally, Seiichi Hamguchi will retire from his position as Executive Officer and transition to a Special Advisor role. These changes are part of CKD’s strategic efforts to strengthen leadership and drive new business initiatives.

The most recent analyst rating on (JP:6407) stock is a Buy with a Yen3400.00 price target. To see the full list of analyst forecasts on CKD Corporation stock, see the JP:6407 Stock Forecast page.

CKD Corporation Increases Year-End Dividend to 42 Yen Per Share
May 13, 2025

CKD Corporation announced an increase in its year-end dividend to 42 yen per share, up from the previous forecast of 41 yen, resulting in a total annual dividend of 80 yen per share. This decision reflects the company’s commitment to shareholder returns while maintaining a target dividend payout ratio of 40% and supporting business expansion through strategic investments.

The most recent analyst rating on (JP:6407) stock is a Buy with a Yen3400.00 price target. To see the full list of analyst forecasts on CKD Corporation stock, see the JP:6407 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.